Adding Lilly’s new drug to Zepbound helped people lose more weight — but there were more side effects

InvestorsWire.com brief · 46d ago · 1 min read · via marketwatch.com

The pharma giant is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes.

The pharma giant is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes. This story matters for Finance & Markets readers tracking finance. Reported by marketwatch.com. Read the full original at the source link below.

Originally reported by marketwatch.com. InvestorsWire.com curates and briefs the finance & markets stories that matter. Our editorial policy →
Get the daily finance & markets signal

More from InvestorsWire.com

Related ventures